DASH vs TERN
DoorDash, Inc. Class A Common Stock (DASH) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the DASH and TERN stock pages for the full models.
Not investment advice.